Home » Topics » Disease categories and therapies » Immune

Immune
RSS

NIH offers type I TNF receptor regulator for licensing

Aug. 17, 2000

Roche's CellCept approved for third organ rejection indication

Aug. 16, 2000

Chiron's Menjugate approved in Ireland

Aug. 10, 2000

New peptides under development at Ludwig Institute

Aug. 9, 2000

New IL-5 inhibitors under development at Janssen

Aug. 8, 2000

New TNF inhibitors under development at Daiichi

Aug. 7, 2000

Peptide Therapeutics awarded SBIR grant for West Nile vaccine

Aug. 4, 2000

New human lymphocytic membrane proteins under study at Incyte

Aug. 3, 2000

Improved recombinant HBsAg for use in vaccines under study at Merck

Aug. 2, 2000

Rapamune regulatory application receives negative opinion from CPMP

Aug. 1, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...